NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/23/2024
Back to search
Official data from USPTO
OT OHIO CLINICAL TRIALS, INC.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
07/23/2024
Classification
Registered
Trademark type
Combined
Nice classes
42
Filing date
03/06/2023
Registration date
07/23/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/23/2024
Last transaction
07/23/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
08/15/2022
First use in commerce
08/15/2022
Drawing code
3
Owner type
16
Owner location
New Providence, NJ
Examiner
MACIOL II,EUGENE VALENTINE-JO
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of an "O" and "T" overlapping design with the words "OHIO CLINICAL TRIALS, INC." directly to the right of the design.
Holders and representatives
Holders
Evolution Research Group, LLC
Representatives
Michael A. Geller DLA Piper LLP (US)
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical and scientific research involving the design and conduct of clinical trials
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/23/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/07/2024
PUBO
PUBLISHED FOR OPPOSITION
05/07/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/17/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/01/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
02/28/2024
ALIE
ASSIGNED TO LIE
02/28/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/28/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
02/28/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/28/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/19/2023
GNRT
NON-FINAL ACTION E-MAILED
12/19/2023
CNRT
NON-FINAL ACTION WRITTEN
12/19/2023
DOCK
ASSIGNED TO EXAMINER
12/04/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
06/29/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/29/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/29/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/29/2023
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/28/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/25/2023
NWAP
NEW APPLICATION ENTERED
03/09/2023
Continuous trademark protection
Get notified about every new filing that threatens OT OHIO CLINICAL TRIALS, INC. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.